Literature DB >> 9169486

Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.

S Lukomski1, S Sreevatsan, C Amberg, W Reichardt, M Woischnik, A Podbielski, J M Musser.   

Abstract

Cysteine proteases have been implicated as important virulence factors in a wide range of prokaryotic and eukaryotic pathogens, but little direct evidence has been presented to support this notion. Virtually all strains of the human bacterial pathogen Streptococcus pyogenes express a highly conserved extracellular cysteine protease known as streptococcal pyrogenic exotoxin B (SpeB). Two sets of isogenic strains deficient in SpeB cysteine protease activity were constructed by integrational mutagenesis using nonreplicating recombinant plasmids containing a truncated segment of the speB gene. Immunoblot analyses and enzyme assays confirmed that the mutant derivatives were deficient in expression of enzymatically active SpeB cysteine protease. To test the hypothesis that the cysteine protease participates in host mortality, we assessed the ability of serotype M3 and M49 wild-type strains and isogenic protease-negative mutants to cause death in outbred mice after intraperitoneal inoculation. Compared to wild-type parental organisms, the serotype M3 speB mutant lost virtually all ability to cause mouse death (P < 0.00001), and similarly, the virulence of the M49 mutant was detrimentally altered (P < 0.005). The data unambiguously demonstrate that the streptococcal enzyme is a virulence factor, and thereby provide additional evidence that microbial cysteine proteases are critical in host-pathogen interactions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169486      PMCID: PMC508102          DOI: 10.1172/JCI119445

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Extracellular antigens in steady-state cultures of the hemolytic Streptococcus: production of proteinase at low pH.

Authors:  C A OGBURN; T N HARRIS; S HARRIS
Journal:  J Bacteriol       Date:  1958-08       Impact factor: 3.490

2.  Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.

Authors:  D R Johnson; D L Stevens; E L Kaplan
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

3.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.

Authors:  J M Musser; A R Hauser; M H Kim; P M Schlievert; K Nelson; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

4.  Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1beta convertase) alters proteolytic activity and ablates zymogen processing.

Authors:  J M Musser; K Stockbauer; V Kapur; G W Rudgers
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children.

Authors:  F R Cockerill; K L MacDonald; R L Thompson; F Roberson; P C Kohner; J Besser-Wiek; J M Manahan; J M Musser; P M Schlievert; J Talbot; B Frankfort; J M Steckelberg; W R Wilson; M T Osterholm
Journal:  JAMA       Date:  1997-01-01       Impact factor: 56.272

6.  What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factors.

Authors:  A Podbielski; M Woischnik; B Pohl; K H Schmidt
Journal:  Med Microbiol Immunol       Date:  1996-11       Impact factor: 3.402

7.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.

Authors:  V Kapur; M W Majesky; L L Li; R A Black; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers.

Authors:  J R DiPersio; T M File; D L Stevens; W G Gardner; G Petropoulos; K Dinsa
Journal:  Clin Infect Dis       Date:  1996-03       Impact factor: 9.079

9.  Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.

Authors:  D F Talkington; B Schwartz; C M Black; J K Todd; J Elliott; R F Breiman; R R Facklam
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes.

Authors:  S S Twining
Journal:  Anal Biochem       Date:  1984-11-15       Impact factor: 3.365

View more
  96 in total

1.  Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae?

Authors:  I Ginsburg
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

Review 2.  Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.

Authors:  S D Reid; N P Hoe; L M Smoot; J M Musser
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins.

Authors:  M Collin; A Olsén
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

Review 5.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  An amino-terminal signal peptide of Vfr protein negatively influences RopB-dependent SpeB expression and attenuates virulence in Streptococcus pyogenes.

Authors:  Samuel A Shelburne; Randall J Olsen; Nishanth Makthal; Nicholas G Brown; Pranoti Sahasrabhojane; Ebru M Watkins; Timothy Palzkill; James M Musser; Muthiah Kumaraswami
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

7.  Comparative proteomic analyses of Streptococcus suis serotype 2 cell wall-associated proteins.

Authors:  Yingchao Wang; Yuan Dang; Xinglong Wang; Hao Lu; Xiuran Wang; Xulong Lang; Xiaoyan Li; Shuzhang Feng; Fuxian Zhang; Linzhu Ren
Journal:  Curr Microbiol       Date:  2010-09-08       Impact factor: 2.188

8.  Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64.

Authors:  R Raeder; E Harokopakis; S Hollingshead; M D Boyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

9.  Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.

Authors:  Stephen B Beres; Gail L Sylva; Kent D Barbian; Benfang Lei; Jessica S Hoff; Nicole D Mammarella; Meng-Yao Liu; James C Smoot; Stephen F Porcella; Larye D Parkins; David S Campbell; Todd M Smith; John K McCormick; Donald Y M Leung; Patrick M Schlievert; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

10.  Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis.

Authors:  Randall J Olsen; Izabela Sitkiewicz; Ara A Ayeras; Vedia E Gonulal; Concepcion Cantu; Stephen B Beres; Nicole M Green; Benfang Lei; Tammy Humbird; Jamieson Greaver; Ellen Chang; Willie P Ragasa; Charles A Montgomery; Joiner Cartwright; Allison McGeer; Donald E Low; Adeline R Whitney; Philip T Cagle; Terry L Blasdel; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.